| |
| |
|
| Insider
Information: |
Kasinger James R. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
61,174 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,259,962 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,174 |
|
|
| Total
Value |
$3,259,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -85.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-03-12 |
61,174 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2024-03-12 |
4 |
S |
$74.44 |
$85,308 |
D/D |
(1,146) |
61,174 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
62,320 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2024-03-11 |
4 |
S |
$78.26 |
$219,206 |
D/D |
(2,801) |
60,070 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
62,871 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2024-02-20 |
4 |
S |
$79.67 |
$152,409 |
D/D |
(1,913) |
57,371 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,825 |
59,284 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2023-03-13 |
4 |
D |
$43.22 |
$99,622 |
D/D |
(2,305) |
54,844 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2023-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
55,866 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,833 |
54,899 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2023-02-21 |
4 |
D |
$48.26 |
$94,107 |
D/D |
(1,950) |
52,066 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,825 |
54,016 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2022-12-05 |
4 |
D |
$52.26 |
$169,009 |
D/D |
(3,234) |
50,191 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2022-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
53,425 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2022-03-14 |
4 |
D |
$61.08 |
$63,462 |
D/D |
(1,039) |
46,429 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2022-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
47,468 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2022-03-11 |
4 |
D |
$62.56 |
$82,642 |
D/D |
(1,321) |
45,218 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,834 |
46,539 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-12-06 |
4 |
D |
$69.17 |
$435,979 |
D/D |
(6,303) |
43,542 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,333 |
49,845 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-12-02 |
4 |
OE |
$13.62 |
$99,998 |
D/D |
7,342 |
36,512 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-09-13 |
4 |
D |
$117.86 |
$558,774 |
D/D |
(4,741) |
29,170 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
33,911 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-03-10 |
4 |
D |
$124.15 |
$167,975 |
D/D |
(1,353) |
23,911 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,833 |
25,264 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
General Counsel and Secretary |
• – – |
2021-01-19 |
4 |
AS |
$203.58 |
$5,635,944 |
D/D |
(27,500) |
22,431 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
